The inhibitors of GAGE4 are a group of compounds that modulate cellular processes and gene expression patterns to suppress the activity of this specific protein. By targeting histone deacetylases, several of these compounds modify the chromatin structure, leading to an increased acetylation state of histones. This modification alters the transcriptional landscape, including the expression of GAGE4, resulting in its decreased expression. These inhibitors, which include hydroxamic acid derivatives and cyclic peptides, induce epigenetic changes that silence GAGE4 expression. Benzamide derivatives in this class also act through similar mechanisms, imposing an epigenetic blockade on the expression of GAGE4, thereby inhibiting its functional activity within the cell. The modulation of chromatin state is a critical aspect of these inhibitors' function, as it directly impacts the transcriptional regulation of genes, including those like GAGE4 that may be involved in various cellular processes.
Another subset of GAGE4 inhibitors disrupts nucleotide synthesis and DNA replication, crucial for the proliferation and survival of cells expressing GAGE4. Some compounds limit the availability of one-carbon units necessary for the synthesis of purine and thymidylate, which are essential components in the synthesis of nucleic acids. The disruption of nucleic acid synthesis impedes cell replication, particularly affecting cells with high levels of GAGE4 expression. Nucleoside and pyrimidine analogs also exert their effects by incorporating into DNA strands during replication or by inhibiting enzymes like thymidylate synthase, thereby causing a malfunction in DNA synthesis and function. Furthermore, ribonucleotide reductase inhibitors deplete the nucleotide pools necessary for DNA replication, contributing to the inhibition of GAGE4-associated cell growth. Other inhibitors, by inhibiting DNA methyltransferases, lead to DNA hypomethylation, which can further impact the gene expression profile, including the downregulation of GAGE4.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
This hydroxamic acid functions as a histone deacetylase inhibitor, altering chromatin structure and gene expression. Inhibition of histone deacetylase can lead to the suppression of GAGE4 expression by increasing the acetylation of histones associated with the GAGE4 gene promoter. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
A histone deacetylase inhibitor that can modify chromatin architecture and gene expression. This modification can downregulate GAGE4 expression through epigenetic silencing. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $214.00 $622.00 | 1 | |
As a cyclic peptide and histone deacetylase inhibitor, Romidepsin alters gene expression by affecting chromatin structure. Epigenetic changes induced by Romidepsin can result in decreased GAGE4 expression. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
A benzamide histone deacetylase inhibitor that can modulate chromatin structure and gene expression profiles, leading to downregulation of GAGE4. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
This hydroxamic acid-based histone deacetylase inhibitor can change the chromatin state and gene expression patterns, leading to a decrease in GAGE4 expression through epigenetic regulation. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $153.00 $561.00 | ||
A histone deacetylase inhibitor which can influence gene expression by modifying chromatin structure, which may contribute to the suppression of GAGE4. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Known as a histone deacetylase inhibitor, Valproic acid can alter chromatin dynamics and gene expression, leading to the reduced expression of GAGE4. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Inhibits dihydrofolate reductase, leading to reduced availability of one-carbon units necessary for purine and thymidylate synthesis, which are essential for DNA synthesis and cell division, inhibiting the proliferation of cells expressing GAGE4. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
As a pyrimidine analog, it inhibits thymidylate synthase, leading to disruption of DNA synthesis and function, which could inhibit cell growth and division of cells expressing GAGE4. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $76.00 $255.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, leading to a decrease in deoxyribonucleotide pools and consequent inhibition of DNA synthesis, affecting cells with high GAGE4 expression levels. | ||||||